Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 11, 2022 12:00 ET | Source: DelveInsight Business Research LLP

Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Insights | DelveInsight

New York, USA, July 11, 2022 (GLOBE NEWSWIRE) -- Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Insights | DelveInsight Metastatic castration-resistant prostate cancer...
November 17, 2021 09:15 ET | Source: Biosplice Therapeutics, Inc.

First Subject Dosed in Biosplice Therapeutics Phase 1b Clinical Trial in Oncology

SAN DIEGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for major...
December 11, 2018 08:00 ET | Source: eFFECTOR Therapeutics

eFFECTOR Initiates Dosing in Phase 2 Trial of Tomivosertib (eFT508) in Advanced Castrate-Resistant Prostate Cancer (CRPC)

SAN DIEGO, Dec. 11, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., (eFFECTOR), a leader in the development of selective translation regulators (STRs) for the treatment of cancer, announced...